Feasibility of dose painting using volumetric modulated arc optimization and delivery

References

• Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993;38:653–66.
   PubMed Web of Science ®Google Scholar
• Webb S, Evans PM, Swindell W, Deasy JO. A proof that uniform dose gives the greatest TCP for fixed integral dose in the planning target volume. Phys Med Biol 1994; 39:2091–8.
   PubMed Web of Science ®Google Scholar
• Levin-Plotnik D, Hamilton RJ. Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols. Phys Med Biol 2004; 49:407–24.
   PubMed Web of Science ®Google Scholar
• Brahme A, Agren AK. Optimal dose distribution for eradication of heterogeneous tumours. Acta Oncol 1987;26:377–85.
   PubMed Web of Science ®Google Scholar
• Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S, . Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551–60.
   PubMed Web of Science ®Google Scholar
• Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, . A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001;49:1171–82.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 2005;6:112–7.
   PubMed Web of Science ®Google Scholar
• Yang Y, Xing L. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology. Med Phys 2005;32:3666–77.
   PubMed Web of Science ®Google Scholar
• Malinen E, Sovik A, Hristov D, Bruland OS, Olsen DR. Adapting radiotherapy to hypoxic tumours. Phys Med Biol 2006;51:4903–21.
   PubMed Web of Science ®Google Scholar
• Bowen SR, Flynn RT, Bentzen SM, Jeraj R. On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function. Phys Med Biol 2009;54:1483–501.
   PubMed Web of Science ®Google Scholar
• Flynn RT, Bowen SR, Bentzen SM, Rockwell MT, Jeraj R. Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. Phys Med Biol 2008;53:4153–67.
   PubMed Web of Science ®Google Scholar
• Vanderstraeten B, Duthoy W, De GW, De NW, Thierens H. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol 2006;79:249–58.
   PubMed Web of Science ®Google Scholar
• Toma-Dasu I, Dasu A, Brahme A. Dose prescription and optimisation based on tumour hypoxia. Acta Oncol 2009;48:1181–92.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Dose painting and theragnostic imaging: Towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology. Cancer Treat Res 2008;139:41–62.
   PubMedGoogle Scholar
• Busk M, Horsman MR, Overgaard J. Resolution in PET hypoxia imaging: Voxel size matters. Acta Oncol 2008;47: 1201–10.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Soukup M, Alber M. Dose painting with IMPT, helical tomotherapy and IMXT: A dosimetric comparison. Radiother Oncol 2008;86:30–4.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, . Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005;77:18–24.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, . Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 2006;24:727–35.
   PubMed Web of Science ®Google Scholar
• Deveau M, Bowen SR, Westerly D, Jeraj R. Feasibility study of helical TomoTherapy for dose painting. Med Phys 2009;36:2783–4.
   Web of Science ®Google Scholar
• Korreman S, Medin J, Kjaer-Kristoffersen F. Dosimetric verification of RapidArc treatment delivery. Acta Oncol 2009;48:185–91.
   PubMed Web of Science ®Google Scholar
• Ceberg S, Gustafson H, Korreman S, Medin J, Kjær-Kristoffersen F, Bäck S. RapidArcTM treatment verification using polymer gel dosimetry. J Phys: Confer Ser 2008;164: 012052, IOP Publishing.
   Google Scholar
• Grau C, Muren LP, Hoyer M, Lindegaard J, Overgaard J. Image-guided adaptive radiotherapy – integration of biology and technology to improve clinical outcome. Acta Oncol 2008;47:1182–5.
   PubMed Web of Science ®Google Scholar
• Tanderup K, Olsen DR, Grau C. Dose painting: Art or science? Radiother Oncol 2006;79:245–8.
   PubMed Web of Science ®Google Scholar